Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium hydroxide versus macrogol/electrolytes for prevention of opioid-induced constipation in advanced cancer
NL-OMON60767Phase 4Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Oct 2022
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of Magnesium hydroxide and polyethylene glycol 3350 + sodium bicarbonate + sodium chloride + potassium chloride in opioid-induced constipation (OIC) (2 arms), sponsored by Amsterdam University Medical Center. Started Oct 2022; status: recruiting.
02
Drugs
Magnesium hydroxidepolyethylene glycol 3350 + sodium bicarbonate + sodium chloride + potassium chloride
03
Conditions
opioid-induced constipation (OIC)
Beyond the preview
Go deeper on NL-OMON60767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60767.